Daniel Raftery

Biography

    Daniel Raftery is the chief scientific officer and founder of Matrix-Bio, Inc. A nationally recognized expert in the field of metabolomics, he invented the biomarker analysis methodology that forms the core of the company’s technology. He has more than 20 years of experience in nuclear magnetic resonance and mass spectrometry analysis, the gold standards for metabolite biomarker analysis. Raftery is a Medical Education and Research Endowed Professor in the Department of Anesthesia and Pain Medicine and Director of the Northwest Metabolomics Research Center at the University of Washington in Seattle. He is also a member of one of the world’s leading cancer research centers, the Fred Hutchinson Cancer Research Center in Seattle. The National Institutes of Health and U.S. Department of Defense support Raftery’s work. Prior to joining the University of Washington, Raftery was a professor of Analytical and Physical Chemistry at Purdue University in West Lafayette, IN, where Matrix-Bio was founded in 2007. A graduate of Harvard College, Raftery earned his PhD from the University of California, Berkeley. He earned his MBA from the University of Chicago. He completed a National Science Foundation postdoctoral fellowship at the University of Pennsylvania. He has received numerous national and international awards and is widely published.  

Research Interest

    pharmaceutical sciences